Constellation, NRG, KKR and CKX Surge on Earnings Beats, $4 Billion Asset Sale and $1 Billion Investment

Mumbai, 9 November 2026: US stocks saw mixed movements on November 9, 2026, as investors reacted to quarterly earnings, revised forecasts, major acquisitions and corporate announcements. Strong earnings and raised guidance lifted shares of energy and investment firms, while cautious revenue projections weighed on monday.com. Strategic deals, defence contracts and shareholder-return plans also drove significant moves across several companies.

Constellation Raises 2026 Guidance As Nuclear Reliability Lifts Shares 8.52% On Earnings

Constellation Energy reported third-quarter 2026 adjusted operating earnings of $5.06 per share, beating the Wall Street consensus estimate of $3.72. Revenue totalled $9.55 billion, above expectations of $9.21 billion. GAAP net income was $5.19 per share, compared with $2.97 per share in the year-earlier quarter, while adjusted operating earnings increased from $3.04 per share. The adjusted earnings result was 36% above consensus, compared with a 3.7% revenue beat.

The company raised its full-year 2026 adjusted operating earnings guidance for the second time this year, setting a range of $12.50 to $12.80 per share, up from its previous forecast of $11.50 to $12.50. Management cited commercial outperformance in a volatile market, partly offset by higher operating and maintenance expenses.

Nuclear fleet reliability was a key operational highlight. Constellation said its fleet achieved a 99.2% capacity factor from June through August, when the PJM grid recorded peak-load records. The fleet’s third-quarter capacity factor was 97.2%, with 20 planned refuelling outage days completed. Chief Executive Joe Dominguez said the fleet delivered a capacity factor of more than 99% across the summer months.

The presentation also highlighted more than 90 million megawatt-hours of clean baseload generation under long-term contracts extending into the 2040s, including about 8,500 MW of new agreements signed year to date.

Constellation shares were up 8.52% at $271.25 as of 11:18:43 a.m. EST on November 9. The stock had closed at $249.95 previously and opened at $260.46. It reached $271.26 during the session, while the session range showed a low of $247.00.

monday.com Shares Fall 6.80% As Q4 Revenue Guidance Signals Slower Growth

monday.com (NASDAQ: MNDY) reported better-than-expected third-quarter 2026 financial results, but its shares declined as the company’s fourth-quarter revenue guidance fell short of analyst expectations. Revenue increased 19% year-on-year to $377.5 million, exceeding the consensus estimate of $369.18 million. Adjusted earnings per share came in at $2.14, compared with the expected $1.37.

The company also reported record adjusted operating income of $89.4 million, up from $47.5 million in the corresponding quarter last year. Its adjusted operating margin expanded to 24% from 15%, reflecting improved operating performance.

However, monday.com’s fourth-quarter revenue forecast of $380 million to $382 million was below market expectations. The midpoint of $381 million indicates approximately 14% year-on-year growth, compared with the 19% increase recorded in the third quarter. For full-year 2026, the company expects revenue of $1.473 billion to $1.475 billion, representing approximately 20% annual growth, with an adjusted operating margin of around 18%.

The company reported $36 million in annual recurring revenue from AI-related products during the quarter, while its monday agents technology recorded more than six million interactions in less than two quarters. Net dollar retention stood at 108%, and customers generating more than $100,000 in annual recurring revenue increased 33% year-on-year to 2,127.

Co-founders and Co-CEOs Roy Mann and Eran Zinman cited near-term operational headwinds associated with the company’s transition towards becoming an AI-first business. CFO Eliran Glazer also highlighted investments in enterprise sales, products and AI, alongside foreign exchange impacts of 100 to 200 basis points.

monday.com shares declined 6.80% to $81.95 as of 11:23 a.m. EST on November 9, compared with the previous close of $87.93. The stock opened at $83.70 and recorded a session high of $86.79 and a low of $80.00.

Also Read: What Is the New York Stock Exchange (NYSE)?

KKR Shares Rise 2.62% As Record Q3 Profit Supports $40 Billion Investor Returns

KKR & Co. (NYSE: KKR) reported record quarterly profit for the third quarter of 2026, supported by higher asset sales and management fees, while announcing plans to return more than $40 billion to clients during the year. The investment firm’s adjusted net income increased 29% year-on-year to $1.6 billion, or $1.78 per share, exceeding the LSEG analyst consensus of $1.59 per share.

The earnings result also surpassed the Zacks Consensus Estimate of $1.58 per share, representing a positive surprise of 12.66%. Revenue for the quarter ended September 2026 reached $1.86 billion, compared with $1.46 billion in the year-earlier period, exceeding the Zacks consensus estimate by 5.96%.

KKR said its planned investor distributions of more than $40 billion in 2026 would represent an increase of over 50% from its previous annual record. The company raised $25 billion in fresh capital during the third quarter, while total assets under management crossed $800 billion.

Co-Chief Executives Joseph Bae and Scott Nuttall said the firm continued to monetise investments and return capital to clients at record levels. Third-quarter transactions included the sale of data centre cooling company CoolIT Systems and private aviation infrastructure platform Atlantic Aviation. KKR also reported record fee-related earnings during the quarter.

The results came as the investment management industry faced slower asset sales amid higher interest rates, although KKR increased its investment exit activity and capital distributions.

KKR shares were trading at $99.01, up 2.62%, as of 11:24:37 a.m. EST on November 9. The stock had previously closed at $96.48 and opened at $97.75. It recorded a high of $99.19 and a low of $95.51 during the session.

NRG Energy Shares Jump 9.53% As $4 Billion Asset Sale Boosts Buyback Plans

NRG Energy (NYSE: NRG) reported stronger-than-expected third-quarter 2026 results, supported by contributions from acquired LS Power assets, higher capacity prices in the East and improved Texas margins. Adjusted earnings reached $4.68 per share, surpassing the Zacks Consensus Estimate of $3.44 by 36.05% and increasing 68.3% from $2.78 in the year-earlier quarter.

Revenue rose 24% year-on-year to $9.47 billion, exceeding the consensus estimate of $6.73 billion. Adjusted EBITDA increased 67.1% to $2.01 billion from $1.21 billion, while adjusted net income climbed to $983 million from $537 million. East segment adjusted EBITDA surged to $614 million from $107 million, reflecting acquired generation assets and higher realised capacity prices.

Alongside its earnings, NRG announced a definitive agreement to sell six natural gas-fired generation facilities with a combined capacity of approximately 4.9 GW to LS Power for $4 billion in cash. The transaction, valued at 8 times estimated 2027 adjusted EBITDA, is expected to close in the second quarter of 2027, subject to regulatory approvals.

The company plans to allocate $2 billion towards debt reduction, $1 billion towards additional share repurchases and retain $1 billion for potential investments or further debt repayment. The additional buyback would bring its planned 2026-2027 repurchases to $3 billion.

NRG introduced 2027 adjusted earnings guidance of $8.05-$10.05 per share and reaffirmed its 2026 forecast of $7.90-$9.90 per share. It also maintained its target of at least 14% annual compound growth in adjusted earnings and free cash flow per share through 2030.

NRG shares rose 9.53% to $96.71 as of 11:38:33 a.m. EST on November 9, compared with the previous close of $88.29. The stock opened at $93.50 and recorded a session high of $97.30 and a low of $90.23.

Barrick Shares Rise 4.03% As Earnings Beat Estimates and Output Guidance Holds

Barrick Mining (NYSE: B; TSX: ABX) reported third-quarter 2026 adjusted earnings per share of $0.82, exceeding the analyst consensus of $0.79. Revenue increased 22% year-on-year to $5.07 billion, driven by higher realised gold prices, but fell short of the $5.13 billion analyst estimate. Adjusted earnings per share rose from $0.58 a year earlier, while adjusted net earnings increased 37% to $1.35 billion.

The company produced 816,000 ounces of gold, up 3% from the second quarter but down 2% year-on-year. Barrick reiterated its 2026 gold production guidance of 2.90 million to 3.25 million ounces, with a midpoint of 3.08 million ounces. Its copper production forecast also remained unchanged at 190,000 to 220,000 tonnes.

Attributable adjusted EBITDA rose 22% to $2.47 billion. However, gold all-in sustaining costs increased 24% year-on-year to $1,911 per ounce, reflecting lower grades processed, higher royalties linked to elevated gold prices, increased diesel costs and sustaining capital expenditure. The company generated $2.49 billion in operating cash flow, while attributable free cash flow declined 44% to $642 million.

Operationally, Cortez benefited from the continued Goldrush ramp-up, while Carlin’s Gold Quarry roaster recorded a quarterly production record. Loulo-Gounkoto output increased 16% from the previous quarter, with its ramp-up progressing ahead of schedule. Production was affected by extreme weather at Veladero in Argentina and delayed access to higher-grade material at North Mara in Tanzania.

Barrick shares traded at $42.20, up $1.63 or 4.03%, as of 11:44:07 a.m. EST on November 9, 2026, with the market open. The stock opened at $42.30, compared with the previous close of $40.56, and moved between a session low of $41.78 and a high of $42.85.

Somnigroup Shares Gain 2.23% After Premarket Selloff Despite Q3 Sales Forecast Miss

Somnigroup International reported third-quarter 2026 adjusted earnings per share of $1.04, below the $1.05 analysts expected, while revenue of $2.35 billion missed the $2.43 billion consensus by $80 million. Adjusted EPS increased 10% year-on-year, and the company described the period as its strongest quarter for net sales, adjusted EBITDA and earnings.

Adjusted EBITDA reached a quarterly record of $448 million. Operating cash flow was $349 million. The company reported consolidated debt, less cash, of $5.0 billion and leverage of 2.7 times.

Management attributed the shortfall to macroeconomic pressure, transportation costs and an operational disruption at Dreams, its international subsidiary. The ERP disruption was estimated to have reduced sales by about $50 million and adjusted EBITDA by $25 million. Mattress Firm generated $1.0 billion in sales, while like-for-like sales declined 4% at Tempur Sealy North America. International sales fell 12%.

The August acquisition of Leggett & Platt expanded Somnigroup’s manufacturing and component supply operations. Management expects about $125 million in incremental adjusted EBITDA synergies in 2027. It cited demand for the new Stearns & Foster range and plans to launch the next-generation Tempur-Pedic Breeze in March 2027.

For 2026, Somnigroup maintained adjusted EPS guidance of $2.85 to $2.95 and forecast sales of approximately $8.65 billion after intercompany eliminations.

Shares initially fell 6.58% in premarket trading to $59.95, below the previous close of $64.17. By 11:46:29 a.m. EST on November 9, shares traded at $65.60, up $1.43 or 2.23%. They opened at $62.95 and ranged from $62.17 to $65.83 during the session.

Also Read: How to invest in US stocks

Surgery Partners Shares Jump 12.48% As HealthSpan Raises Offer Following Rival Bid

Surgery Partners (NASDAQ: SGRY) and HealthSpan Partners amended their merger agreement, raising cash consideration to $25 per share after an unsolicited competing proposal. The revised deal values the company at up to $6.0 billion, including potential additional payments if closing extends beyond March 1, 2027.

Under the amended terms, stockholders other than Bain Capital affiliates will receive $25 per share if the transaction closes before March 1. If shareholder approval is obtained before that date but closing occurs later, eligible holders will receive ticking fees at an annual rate of 10% on the $25 consideration. The maximum additional payment is $1.61 per share if the deal closes on October 23, 2027, bringing potential consideration to $26.61.

The amendment followed a third-party proposal, submitted November 3 and updated November 8, to acquire Surgery Partners for $28 per share in cash. The board’s Special Committee concluded that the offer did not qualify as a superior proposal, citing a longer closing timeline, regulatory complexity and insufficient contractual protections. The board approved the amended HealthSpan agreement and recommended that shareholders vote in favour.

Bain Capital, which owns approximately 39% of Surgery Partners, will roll over its shares into equity in the acquiring entity rather than receive cash. The transaction is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals. HealthSpan intends to finance the acquisition through cash and committed debt.

Surgery Partners shares traded at $26.10, up $2.89 or 12.48%, as of 11:45:21 a.m. EST on November 9, 2026. The stock opened at $25.81, compared with the previous close of $23.20, and ranged from $25.77 to $27.23.

Reliance Global Shares Rise 19.31% As Company Rebrands Around GPU Cloud And AI Infrastructure

Reliance Global Group (NASDAQ: EZRA) announced that its Nasdaq ticker symbol will change from “EZRA” to “XGPU”, effective at the market open on November 10, 2026. The company’s common stock will remain listed on the Nasdaq Capital Market, and its CUSIP number will remain unchanged. Shareholders are not required to take any action regarding the transition.

The symbol change reflects Reliance Global’s strategic entry into the GPU cloud and artificial intelligence infrastructure market following its acquisition of assets from Oblivus, completed on November 3. Oblivus operates as a GPU cloud provider and marketplace. The acquisition was conducted through GPU Exchange Corp., a newly formed, wholly owned subsidiary, in an all-cash transaction funded from the company’s existing cash resources. Reliance Global said it issued no common shares as consideration.

Alongside the ticker transition, the company is adopting “GPU Exchange” as its doing-business-as name, with the acquired business operating under that brand. Its legal corporate name will remain Reliance Global Group, Inc. Chief Executive Officer Ezra Beyman said the new symbol aligns the company’s public identity with its developing AI infrastructure business. Management’s priorities include expanding GPU computing capacity, growing the GPU Exchange marketplace and pursuing long-term shareholder value.

The company will continue operating and developing its RELI Exchange Insurtech platform alongside its new business activities. Reliance Global’s existing insurance and technology operations therefore remain part of its business as it expands into AI-related infrastructure.

Reliance Global shares were indicated up 19.31% in the supplied market data. The provided information does not include a share price, previous close, opening price or session range. The new ticker symbol is scheduled to take effect on November 10, rather than during the November 9 trading session.

Quanterix Shares Gain 15.37% as Q3 Revenue Beats Estimates, Despite EPS Miss

Quanterix Corporation reported third-quarter 2026 revenue of $35.0 million, up 6.3% sequentially and above the analyst estimate of $33.85 million. However, its diluted loss per share of $0.46 was wider than the estimated loss of $0.44. The company recorded a GAAP net loss of $21.6 million, an improvement of 35.6% from the $33.5 million loss reported a year earlier.

GAAP gross margin was 38.6%, down 90 basis points year-on-year, while adjusted gross margin increased 150 basis points to 47.4%. Adjusted EBITDA loss widened 2.4% to $12.2 million. Quanterix ended the quarter with $80.7 million in cash, cash equivalents, marketable securities and restricted cash. It reported no debt and expects to finish 2026 with approximately $70 million in cash.

The company said commercial initiatives include new laboratory partnerships in New York and Mississippi, expanded Florida insurance coverage for qualifying blood-based biomarker tests, and regulatory approvals in China for neurology biomarker testing using its HD-X and SR-X instruments. It also expanded its Simoa assay menu and released the PhenoCode 2.0 Molecular Barcoding Kit. Two additional spatial biology panels are expected to ship in early 2027.

Quanterix narrowed its 2026 revenue outlook to $142 million-$146 million for the full 2026 financial year and maintained its adjusted gross margin target of 48%-50%. Quanterix shares were trading at $3.41, up 17.99% from the previous closing price of $2.89, as of 11:46 a.m. EST on November 9, 2026. The stock opened at $2.91 and recorded a high of $3.44 and a low of $2.827 during the session.

QXO Shares Surge 18.73% as Q3 Net Sales Jump 79% to $4.90 Billion

QXO, Inc. announced preliminary third-quarter 2026 net sales of approximately $4.90 billion, marking a 79% increase from $2.73 billion in the corresponding quarter last year. The building products distributor reported a GAAP net loss of approximately $123 million, compared with a loss of $139 million in the year-ago period. Adjusted EBITDA increased 85% to $557 million from $301 million.

The company’s adjusted EBITDA margin improved to 11.4% from 11.1% in the third quarter of 2025, while its net margin improved to negative 2.5% from negative 5.1%. The preliminary results include contributions from Kodiak Building Partners, acquired from April 1, 2026, and TopBuild Corp., consolidated from July 1, 2026. Neither business contributed to the corresponding quarter’s results in 2025.

QXO stated that the preliminary unaudited figures remain subject to finalisation of its quarter-end financial and accounting procedures. The company plans to announce its complete third-quarter results on November 12, 2026.

Share Price Response: QXO shares were trading at $13.73, up 18.73% from the previous closing price of $11.56, as of 12:34:56 p.m. EST on November 9, 2026. The stock opened at $12.65 and recorded a high of $13.73 and a low of $12.40 during the session.

Also Read: US Stock Market Timings 

argenx Shares Rise 3.32% as $1.15 Billion Unnatural Products Acquisition Expands Drug Discovery

argenx SE announced an agreement to acquire biotechnology company Unnatural Products for $550 million upfront, with additional contingent value rights linked to development and regulatory milestones. The transaction could reach approximately $1.15 billion in total value and is expected to close by the end of 2026, subject to customary closing conditions.

The acquisition builds on a two-year, multi-target research collaboration between the companies. Unnatural Products develops orally delivered macrocyclic peptides using a discovery platform combining artificial intelligence-guided design, parallel synthesis and direct-to-biology screening. These molecules combine characteristics of biologics with the convenience of oral administration and can target intracellular pathways that conventional drugs may not reach.

Following the transaction, Unnatural Products will continue operating from its Santa Cruz, California facility as part of argenx’s global research organisation. Argenx said the acquisition will complement its existing antibody engineering capabilities with macrocyclic peptide technology. The companies also highlighted their established research partnership and alignment in scientific development.

argenx shares (NASDAQ: ARGX) were trading at $958.03, up 3.32% from the previous closing price of $927.21, as of 12:37:40 p.m. EST on November 9, 2026. The stock opened at $946.13 and recorded a high of $958.33 and a low of $935.57 during the session.

CKX Lands Shares Surge 85.15% as Brad Jacobs Leads $1 Billion Investment

CKX Lands Inc. shares surged after the company announced a $1 billion cash investment led by billionaire businessman Brad Jacobs. Under the agreement, Jacobs Private Equity II (JPE) will contribute $900 million, while minority co-investors led by HRTG Partners, formerly Sequoia Heritage, will provide the remaining $100 million.

Upon completion of the transaction, JPE will hold a majority stake in CKX, and Jacobs will become its chairman and chief executive officer. The company plans to change its name and operate as a standalone publicly traded business platform, although the industry it intends to enter has not yet been disclosed. The investment remains subject to closing conditions.

Jacobs has founded and led eight billion-dollar or multibillion-dollar businesses, including QXO, XPO, GXO Logistics, RXO, United Rentals and United Waste Systems. He has also overseen approximately 500 mergers and acquisitions. He described the CKX investment as the launch of his ninth company while confirming that he would continue serving as chairman and CEO of QXO.

CKX Lands shares (NYSE: CKX) were trading at $19.20, up 85.15% from the previous closing price of $10.37, as of 12:34:28 p.m. EST on November 9, 2026. The stock opened at $17.50 and recorded a high of $20.79 and a low of $15.08 during the session.

Windward Bio Targets $185 Million Nasdaq IPO With Shares Priced at $16-$18

Windward Bio is planning an initial public offering (IPO) of 10,294,117 common shares on the Nasdaq Global Market under the proposed ticker symbol WWB. The company has set an estimated offering price range of $16 to $18 per share, which could raise approximately $165 million to $185 million. Underwriters also have an option to purchase up to 1,544,117 additional shares within 30 days of the final prospectus.

Separately, Windward Bio has entered into a securities purchase agreement with Sanofi Foreign Participations B.V., a subsidiary of Sanofi, for a concurrent $50 million private placement. Sanofi has agreed to purchase 1,532,691 common shares and pre-funded warrants for another 1,408,485 shares, based on an assumed price of $17 per share.

Jefferies, TD Cowen, Piper Sandler and UBS Investment Bank are managing the offering. Windward Bio currently has no public trading market for its shares, and its Nasdaq listing application remains subject to approval. The IPO will not proceed if the application is rejected.

LifeStance Health Prices 45 Million-Share Offering at $13.12, Plans 2 Million-Share Buyback

LifeStance Health Group, Inc. (NASDAQ: LFST) announced the pricing of a secondary public offering of 45 million common shares at $13.12 per share by certain existing stockholders. The company will not issue shares or receive proceeds from the offering, with the entire proceeds going to the selling stockholders. Barclays and J.P. Morgan are serving as underwriters for the transaction.

Separately, LifeStance has agreed to repurchase 2 million shares from the underwriters at the same price they pay the selling stockholders. The repurchase is conditional on the completion of the offering and other customary conditions. Both transactions are expected to settle on or around November 12, 2026.

LifeStance operates virtual and in-person outpatient mental healthcare services across 35 states and more than 550 centres, employing over 8,800 mental health professionals.

LifeStance shares were trading at $14.36, up 4.25% from the previous closing price of $13.77, as of 12:32:51 p.m. EST on November 9, 2026. The stock opened at $13.70 and recorded a high of $14.41 and a low of $13.20 during the session.

Hyperscale Data Shares Jump 32.96% as Company Proposes $50 Million Share Exchange Offer

Hyperscale Data, Inc. (NYSE American: GPUS) announced plans to launch an exchange offer to acquire up to 192.3 million outstanding Class A common shares for a total value of up to $50 million. Under the proposal, shareholders can exchange every 100 common shares for $2 in cash and one preferred share with a stated value of $24, valuing the common stock at $0.26 per share. The preferred stock will carry an annual dividend of 12%.

The proposed exchange price represents an 82% premium to the November 6 closing price of $0.1429. The offer requires at least 100 million common shares to be tendered. Hyperscale Data expects to launch it around November 17, subject to board and regulatory approvals. The company also intends to seek NYSE American listing for the new preferred shares.

GPUS shares were trading at $0.1900, up 32.96% from the previous closing price of $0.1429, as of 12:45:11 p.m. EST on November 9, 2026. The stock opened at $0.1713 and recorded a high of $0.2110 and a low of $0.1640 during the session.

Also Read: What Are Fractional Shares? 

AeroVironment Gains 12.11% After Securing $940 Million Defense Contract Ceiling

AeroVironment, Inc. (NASDAQ: AVAV) announced that it has received a multiyear indefinite-delivery, indefinite-quantity contract with a ceiling of $940 million from a U.S. customer. The agreement includes an initial award of approximately $315 million for product deliveries and support.

The contract is expected to support the delivery of capabilities through the company’s AxS segment, covering established product lines. AeroVironment President of AxS Trace Stevenson said the award reflects customer confidence in the company’s ability to move advanced capabilities beyond development and manufacture them at scale.

The announcement did not identify the customer agency or specific programme, citing operational security guidelines. The press release was reviewed and cleared by the U.S. Government Security and Policy Review authority.

AeroVironment cautioned that the contract ceiling does not guarantee orders beyond the initial award. Future orders will depend on funding availability and timing, while the customer retains the right to modify or terminate the agreement.

AVAV shares traded at $126.41, up 12.11% from the previous close of $112.76, as of 12:49:42 p.m. EST on November 9, 2026. The stock opened at $114.77, reached a session high of $126.41 and recorded a low of $111.95.

The latest corporate updates highlighted mixed market reactions to earnings, strategic transactions and business expansion plans. Strong results and raised guidance supported gains for Constellation Energy, KKR and NRG Energy, while monday.com declined on cautious revenue guidance. Defense contract wins, acquisitions, asset sales and shareholder-return initiatives also drove movements across several stocks, underscoring varied investor responses to company developments.